BURLINGTON, Mass., – October 23, 2017 – Nuance Communications, Inc. (NASDAQ: NUAN) today announced it has filed a patent infringement lawsuit in the U.S. Federal District Court of Delaware against M*Modal. The lawsuit alleges that M*Modal products violate six Nuance patents related to speech recognition, computer-assisted physician documentation and transcription technology applied in the healthcare IT market. This lawsuit is based on U.S. Patent
“Nuance has invested significant human and financial resources in developing innovations and building an intellectual property portfolio that are important components of our strategy and integral to the success of our business,” said David Greenbaum, Vice President of Litigation & Intellectual Property, Nuance. “Our IP and technology assets favorably differentiate our voice- and AI-powered offerings in the healthcare industry. We take great pride in, and place significant value on, our patents and will protect our rights.”
Nuance Healthcare provides intelligent systems that support a more natural and insightful approach to clinical documentation, freeing clinicians to spend more time caring for patients. Nuance
About Nuance Communications, Inc.
Nuance Communications, Inc. (NASDAQ: NUAN) is a leading provider of voice and language solutions for businesses and consumers around the world. Its technologies,
Trademark reference: Nuance and the Nuance logo are registered trademarks or trademarks of Nuance Communications, Inc. or its affiliates in the United States and/or other countries. All other trademarks referenced herein are the property of their respective owners.
Nuance Communications, Inc.
Tel: (781) 565-5000